Current Winner
2012 Innovation Challenge Award

Andrew Tait

Insights into Viral Mechanisms of Multiple Sclerosis and the Use of a Botanical Extract from Traditional Chinese Medicine to Reverse Demyelination

Andrew Tait

Andrew Tait's research has led to a better understanding of the role of the protein U24 in myelin degradation—a key factor in neurodegenerative conditions, such as multiple sclerosis. As a result of this research, he has established a company—Tait Laboratories Inc.—to develop and market plant-based extracts found in traditional Chinese medicine that may potentially help many people suffering from neurodegenerative disease associated with aging and multiple sclerosis.